Beth Zelnick Kaufman - 04 Feb 2026 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role: Chief Legal Officer
Signature: /s/ Beth Zelnick Kaufman
Issuer symbol: CRMD
Transactions as of: 04 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 06 Feb 2026, 21:30:06 UTC
Previous filing: 27 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Zelnick Kaufman Beth	Chief Legal Officer	C/O CORMEDIX INC.,, 389 INTERPACE PKWY, SUITE 450, PARSIPPANY	/s/ Beth Zelnick Kaufman	06 Feb 2026	0002004480

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRMD	Common Stock	Award	$0	+36,006	+15%	$0.000000	269,108	04 Feb 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the achievement of performance stock units ("PSUs") upon the determination of the Compensation Committee of the Issuer that the performance conditions specific to the first of three performance periods were met with respect to the PSUs granted to the Reporting Person on January 2, 2025. The PSUs are subject to vesting upon satisfaction of time-based vesting conditions by the Reporting Person.

Content

Represents the achievement of performance stock units ("PSUs") upon the determination of the Compensation Committee of the Issuer that the performance conditions specific to the first of three performance periods were met with respect to the PSUs granted to the Reporting Person on January 2, 2025. The PSUs are subject to vesting upon satisfaction of time-based vesting conditions by the Reporting Person.